rs137854521

Variant summary

Our verdict is Pathogenic.
+10 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 10 classification points (ACMG Germline Pathogenicity v2019). PVS1PM2

The NM_213599.3(ANO5):c.191delA (p.Asn64IlefsTer27) variant causes a frameshift change. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The variant has a gnomAD grpmax filtering allele frequency (95% CI) of 0.00000072, indicating it is observed in the general population. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

ANO5
NM_213599.3 frameshift

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.66

Publications

13 publications found
Variant links:
Genes affected
ANO5 (HGNC:27337): (anoctamin 5) This gene encodes a member of the anoctamin family of transmembrane proteins. The encoded protein is likely a calcium activated chloride channel. Mutations in this gene have been associated with gnathodiaphyseal dysplasia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
ANO5 Gene-Disease associations (from GenCC):
  • gnathodiaphyseal dysplasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2L
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Miyoshi muscular dystrophy 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_213599.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 10 points.

PVS1Null variant in LOF gene
Frameshift/stop-gained, NMD predicted, LoF disease mechanism — very strong (PVS1); Frameshift (exon 5 of 22) at amino acid 64 of 913, predicted to trigger nonsense-mediated mRNA decay. Loss of function is a known disease mechanism for this gene. A new stop codon is introduced in the shifted frame, truncating the protein to ~89 amino acids (824 amino acids lost).
PM2Absent/extremely low in population databases
Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.00000072 — very rare for AD+AR gene (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.00208) — PM2 moderate.

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_213599.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ANO5 NM_213599.3
MANE Select
HGVSc / HGVSpc.191delAp.Asn64IlefsTer27
Exon rankExon 5 of 22
frameshift
Prot: NP_998764.1UniProt: Q75V66
ANO5 NM_001142649.2
HGVSc / HGVSpc.188delAp.Asn63IlefsTer27
Exon rankExon 5 of 22
frameshift
Prot: NP_001136121.1
ANO5 NM_001410963.1
HGVSc / HGVSpc.149delAp.Asn50IlefsTer27
Exon rankExon 4 of 21
frameshift
Prot: NP_001397892.1UniProt: A0A804HL91

Ensembl Transcripts

ANO5 ENST00000324559.9
TSL:1MANE Select
HGVSc / HGVSpc.191delAp.Asn64IlefsTer27
Exon rankExon 5 of 22
frameshift
Prot: ENSP00000315371.9UniProt: Q75V66
ANO5 ENST00000682341.1
HGVSc / HGVSpc.149delAp.Asn50IlefsTer27
Exon rankExon 4 of 21
frameshift
Prot: ENSP00000508251.1UniProt: A0A804HL91
ANO5 ENST00000684663.1
HGVSc / HGVSpc.146delAp.Asn49IlefsTer27
Exon rankExon 4 of 21
frameshift
Prot: ENSP00000508009.1UniProt: A0A804HKP2

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:33
GnomAD4 exome Warning
AF: 0.00000206
AC:3
Hom:0
AN:1457088
Cov:29
GnomAD4 genome
Cov:33
Showing 3 sources

ClinVar

Not reported in ClinVar

Computational Scores

PhyloP100
Benign2.7
Showing 1 of 1 scores

Splicing Scores

SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 1 of 1 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.